Related references
Note: Only part of the references are listed.ART suppresses plasma HIV-1 RNA to a stable set point predicted by pretherapy viremia
Frank Maldarelli et al.
PLOS PATHOGENS (2007)
Residual human immunodeficiency virus type 1 viremia in some patients on Antiretroviral therapy is dominated by a small number of invariant clones rarely found in circulating CD4+ T cells
JR Bailey et al.
JOURNAL OF VIROLOGY (2006)
Predictors of residual viremia in HIV-infected patients successfully treated with efavirenz and lamivudine plus either tenofovir or stavudine
DV Havlir et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Kinetics of human immunodeficiency virus type 1 decay following entry into resting CD4+ T cells
Y Zhou et al.
JOURNAL OF VIROLOGY (2005)
Genotypic analysis of HIV-1 drug resistance at the limit of detection: Virus production without evolution in treated adults with undetectable HIV loads
TL Kieffer et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
Long-term safety and durable antiretroviral activity of lopinavir/ritonavir in treatment-naive patients: 4 year follow-up study
C Hicks et al.
AIDS (2004)
Modeling the long-term control of viremia in HIV-1 infected patients treated with antiretroviral therapy
M Di Mascio et al.
MATHEMATICAL BIOSCIENCES (2004)
A long-term latent reservoir for HIV-1: discovery and clinical implications
JD Siliciano et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)
New real-time reverse transcriptase-initiated PCR assay with single-copy sensitivity for human immunodeficiency virus type 1 RNA in plasma
S Palmer et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2003)
Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells
JD Siliciano et al.
NATURE MEDICINE (2003)
Multiple viral genetic analyses detect low-level human immunodeficiency virus type 1 replication during effective highly active antiretroviral therapy
LM Frenkel et al.
JOURNAL OF VIROLOGY (2003)
In a subset of subjects on highly active antiretroviral therapy, human immunodeficiency virus type 1 RNA in plasma decays from 50 to <5 copies per milliliter, with a half-life of 6 months
M Di Mascio et al.
JOURNAL OF VIROLOGY (2003)
Lopinavir-ritonavir versus nelfinavir for the initial treatment of HIV infection
S Walmsley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Correlation between reduction in plasma HIV-1 RNA concentration 1 week after start of antiretroviral treatment and longer-term efficacy
MA Polis et al.
LANCET (2001)
Prevalence and predictive value of intermittent viremia with combination HIV therapy
DV Havlir et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Share Paper
